Heart Transplant Market Size, Share, Growth Analysis, By Type of Transplant(Orthotopic Heart Transplant, Heterotopic Heart Transplant, and Pediatric Heart Transplant), By Donor Type (Deceased Donor Heart Transplant, and Living Donor Heart Transplant), By Indication(Ischemic Cardiomyopathy, Dilated Cardiomyopathy, Congenital Heart Disease, Valvular Heart Disease), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35D2230 | Region: Global | Published Date: March, 2024
Pages: 223 |Tables: 91 |Figures: 76

Heart Transplant Market Insights

Heart Transplant Market size was valued at USD 11.62 Billion in 2023 and is poised to grow from USD 12.84 Billion in 2024 to USD 27.22 Billion by 2032, growing at a CAGR of 10.52% during the forecast period (2025-2032).

The global heart transplant marketplace is marked via important insights into the field of organ transplantation. This market is frequently driven with the aid of the increasing incidence of quit-stage coronary heart sicknesses, prompting a rising demand for coronary heart transplants as a life-saving intervention. Technological advancements in surgical strategies, immunosuppressive treatments, and organ protection strategies further make contributions to the marketplace's boom.

The shortage of donor hearts remains a sizable project, necessitating ongoing efforts to enhance organ procurement and increase transplantation criteria. Additionally, continuous studies endeavors and collaborations in the scientific community are pivotal for advancing results and addressing the complicated demanding situations related to coronary heart transplantation.

 

Market snapshot - 2024-2031

Global Market Size

USD 10.2 billion

Largest Segment

Ischemic Cardiomyopathy

Fastest Growth

Pediatric Cardiomyopathy

Growth Rate

10.52% CAGR

Global Heart Transplant Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Heart Transplant Market Segmental Analysis

The global Heart Transplant market is segmented into four major segments i.e. by Type of Transplant, Donor Type, Indication, and region. Based on Type of Transplant, it is divided into Orthotopic Heart Transplant, Heterotopic Heart Transplant, Pediatric Heart Transplant. Based on Donor Type, it is bifurcated as Deceased Donor Heart Transplant, Living Donor Heart Transplant. Based on Indication it is segregated into, Ischemic Cardiomyopathy, Dilated Cardiomyopathy, Congenital Heart Disease, Valvular Heart Disease, Others. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.

Analysis by Indication

Ischemic cardiomyopathy, often due to coronary artery sickness, is a main purpose of coronary heart failure worldwide, contributing to a high demand for coronary heart transplants. Ischemic cardiomyopathy has nicely-set up remedy pathways, and heart transplantation is regularly taken into consideration a critical intervention for sufferers with give up-stage coronary heart failure due to this condition.

Advances in pediatric cardiology have led to advanced diagnostics and control of congenital coronary heart diseases, growing the survival costs of affected people into maturity, consequently driving the want for coronary heart transplants. Ongoing technological improvements in surgical strategies and artificial coronary heart gadgets gain people with congenital coronary heart diseases, making them capability candidates for coronary heart transplants.

Analysis by Type of Transplant 

Orthotopic heart transplant, regarding the substitute of the recipient's heart with an entire heart from a deceased donor, is the hooked up and widely practiced clinical trendy for heart transplantation. Surgeons are greater acquainted with and have widespread understanding in orthotopic coronary heart transplant procedures. This familiarity contributes to the dominance of this kind within the marketplace.

Heterotopic coronary heart transplant, regarding the addition of a donor coronary heart to the recipient's coronary heart, permits for making use of donor organs that may not meet the standards for orthotopic transplantation. This addresses the essential trouble of donor organ scarcity. Heterotopic transplants often have decreased ischemia time, because the recipient's original heart keeps to feature while the donor coronary heart is introduced. This can make contributions to better outcomes and is an attractive function for sure patient populations.

Global Heart Transplant Market By End Use

To get detailed analysis on other segments, Request For Free Sample Report

Heart Transplant Market Regional Insights

North America boasts a tremendously evolved healthcare infrastructure with superior clinical centres and information in organ transplantation, supplying a conducive environment for heart transplant methods. The region has a particularly excessive prevalence of cardiovascular illnesses, contributing to a bigger pool of ability heart transplant recipients and using the demand for such methods.

The Asia-Pacific area is experiencing a rising burden of cardiovascular illnesses, such as situations necessitating coronary heart transplants. Changing lifestyles, urbanization, and growing old populations contribute to this growth. Growing economies in Asia-Pacific are investing in healthcare infrastructure, fostering better get entry to transplantation facilities. This development complements the place's capability to perform coronary heart transplants and meet the growing demand.

Global Heart Transplant Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Heart Transplant Market Dynamics

Drivers

Increasing Demand for Heart Transplants

The perpetual call for heart transplants pushed through the growing occurrence of stop-level heart diseases international. Advances in surgical techniques, immunosuppressive remedies, and organ maintenance methods similarly decorate the feasibility and success charges of heart transplant strategies, fostering marketplace growth.

Ongoing Research and Collaborations Inside the Scientific Network

Ongoing research and collaborations inside the scientific network make contributions to non-stop enhancements in transplant results.

Restraints

High Persistent Shortage of Donor Organs

  • One of the primary marketplace restraints that is the continual scarcity of donor organs, particularly possible hearts, which limits the quantity of transplant methods that may be accomplished. The complex logistics related to organ procurement, maintenance, and transportation additionally gift demanding situations.

High Rigorous Eligibility Criteria for Both Donors and Recipients

  • The rigorous eligibility criteria for both donors and recipients contribute to the constraint, as not all sufferers may meet the stringent necessities. The excessive fee associated with heart transplant tactics, including put up-operative care and lifelong immunosuppressive medicines, poses a monetary barrier.

Request Free Customization of this report to help us to meet your business objectives.

Heart Transplant Market Competitive Landscape

The competitive surroundings of the Heart Transplant marketplace is characterised by a mix of hooked up clinical establishments, main pharmaceutical corporations, and corporations that specialize in organ transplantation. Prominent players in the marketplace encompass renowned scientific facilities with widespread experience in cardiac surgical procedures and transplant processes, contributing to their management on this specialised field. Pharmaceutical groups play a essential function, presenting immunosuppressive medications integral to publish-transplant care. Additionally, collaborations and partnerships between medical institutions and pharmaceutical firms similarly shape the aggressive dynamics.

Top Player’s Company Profiles

  • Abbott Laboratories
  • Novartis AG
  • Pfizer Inc.
  • Johnson & Johnson
  • Astellas Pharma Inc.
  • Bristol Myers Squibb Company
  • Sanofi S.A.
  • Fresenius SE & Co. KGaA
  • Medtronic plc
  • Merck & Co., Inc.
  • Roche Holdings AG
  • AstraZeneca plc
  • Gilead Sciences, Inc.
  • Novo Nordisk A/S
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Thermo Fisher Scientific Inc.
  • Terumo Corporation
  • Siemens Healthineers AG

Recent Developments

  • August 2023: Beth Israel Lahey Health (BILH) has made a good sized advancement in cardiovascular care with the release of its new coronary heart transplantation application. This application, based totally at Beth Israel Deaconess Medical Center (BIDMC), is the first of its type to be established in New England in many years.
  • July 2023: Stanford Health Care's Heart Transplant Program continues to demonstrate its leadership function, keeping its status as the top program in Northern California by using volume. The July 2023 biannual information from the Scientific Registry of Transplant Recipients (SRTR) verify this excellence, ranking Stanford among the state's top 5 facilities for transplant success fees and results, based totally on the SRTR's five-tier assessment machine.
  • July 2023: Following the arena's first successful transplant in 2022 on the University of Maryland Medical Center (UMMC), the pioneering transplant crew conducted a second pig coronary heart transplant on a affected person deemed ineligible for a conventional coronary heart transplant. On September 20, a fifty eight-12 months-old person with terminal heart sickness became the second one person globally to go through a historic transplant with a genetically-changed pig heart. Currently getting better, the patient is speaking with loved ones, marking the second one instance of a genetically changed pig heart being transplanted right into a residing patient..

 

Heart Transplant Key Market Trends

Rising Emphasis on Genetic Testing: The remarkable trend in the direction of utilizing revolutionary technologies in organ preservation, along with normothermic machine perfusion, enhancing the viability of donor hearts. Additionally, there is a growing recognition on regenerative medicine procedures, exploring the potential of stem cell treatment options to enhance transplant outcomes and mitigate the risk of rejection. Telemedicine and far-flung tracking are rising trends facilitating publish-transplant care, making sure ongoing affected person fitness management.

Heart Transplant Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. 

Global Heart Transplant marketplace evaluation famous a dynamic market with several standout tendencies and problems. The marketplace is driven through the increasing incidence of cease-stage coronary heart diseases, necessitating lifestyles-saving interventions. Technological improvements in surgical methods and immunosuppressive therapies decorate transplant feasibility. However, persistent challenges consist of the dearth of donor organs, stringent eligibility standards, and excessive related fees. Product type evaluation exhibits a reliance on advanced prescription drugs for put up-transplant care. Regionally, North America dominates due to advanced healthcare infrastructure, at the same time as the Asia-Pacific region famous the quickest increase because of rising disorder burdens and improving healthcare abilities. Key trends contain progressive organ renovation technologies, regenerative medication tactics, and a focus on increasing donor pools.

Report Metric Details
Market size value in 2023 USD 10.2 billion
Market size value in 2031 USD 24.63 billion
Growth Rate 10.52%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type of Transplant
    • Orthotopic Heart Transplant, Heterotopic Heart Transplant, and Pediatric Heart Transplant
  • Donor Type 
    • Deceased Donor Heart Transplant, and Living Donor Heart Transplant
  • Indication
    • Ischemic Cardiomyopathy, Dilated Cardiomyopathy, Congenital Heart Disease, Valvular Heart Disease, and Others.
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories
  • Novartis AG
  • Pfizer Inc.
  • Johnson & Johnson
  • Astellas Pharma Inc.
  • Bristol Myers Squibb Company
  • Sanofi S.A.
  • Fresenius SE & Co. KGaA
  • Medtronic plc
  • Merck & Co., Inc.
  • Roche Holdings AG
  • AstraZeneca plc
  • Gilead Sciences, Inc.
  • Novo Nordisk A/S
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Thermo Fisher Scientific Inc.
  • Terumo Corporation
  • Siemens Healthineers AG
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Heart Transplant Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Heart Transplant Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Heart Transplant Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Heart Transplant Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Heart Transplant Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Heart Transplant Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Heart Transplant Market size was valued at USD 10.2 billion in 2022 and is poised to grow from USD 11.62 billion in 2023 to USD 24.63 billion by 2031, growing at a CAGR of 10.52% in the forecast period (2024-2032).

The competitive surroundings of the Heart Transplant marketplace is characterised by a mix of hooked up clinical establishments, main pharmaceutical corporations, and corporations that specialize in organ transplantation. Prominent players in the marketplace encompass renowned scientific facilities with widespread experience in cardiac surgical procedures and transplant processes, contributing to their management on this specialised field. Pharmaceutical groups play a essential function, presenting immunosuppressive medications integral to publish-transplant care. Additionally, collaborations and partnerships between medical institutions and pharmaceutical firms similarly shape the aggressive dynamics. 'Abbott Laboratories', 'Novartis AG', 'Pfizer Inc.', 'Johnson & Johnson', 'Astellas Pharma Inc.', 'Bristol Myers Squibb Company', 'Sanofi S.A.', 'Fresenius SE & Co. KGaA', 'Medtronic plc', 'Merck & Co., Inc.', 'Roche Holdings AG', 'AstraZeneca plc', 'Gilead Sciences, Inc.', 'Novo Nordisk A/S', 'Baxter International Inc.', 'Boston Scientific Corporation', 'Edwards Lifesciences Corporation', 'Thermo Fisher Scientific Inc.', 'Terumo Corporation', 'Siemens Healthineers AG'

One of the primary marketplace restraints that is the continual scarcity of donor organs, particularly possible hearts, which limits the quantity of transplant methods that may be accomplished. The complex logistics related to organ procurement, maintenance, and transportation additionally gift demanding situations.

North America boasts a tremendously evolved healthcare infrastructure with superior clinical centres and information in organ transplantation, supplying a conducive environment for heart transplant methods. The region has a particularly excessive prevalence of cardiovascular illnesses, contributing to a bigger pool of ability heart transplant recipients and using the demand for such methods.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Heart Transplant Market

Report ID: SQMIG35D2230

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE